MAR 16 - 17 2016
Neuroscience
55 193 49189

The 4th Annual world-renowned LabRoots Neuroscience virtual conference is now On Demand. Watch any webcast from the conference any time! Neuroscience 2016 (free to view) aims to help advance knowledge of the brain and nervous system by bringing together research scientists, principal investigators, lab directors, clinicians and medical professionals from around the world to discuss and learn about the latest research and technologies in the field.

Watch This Video
Learn more about the international Neuroscience 2016 Virtual Event!

Neuroscience 2016 included the following topics:

  • Neural Circuitry: New ontogenetic and anatomical methods for defining neural circuits, molecular biology of neural circuits in health and disease, and the need to reconsider clinical trial design for novel drug discovery
  • Neurodegenerative Disorders: Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, spino-cerebellar ataxia, common pathological aspects of neurodegenerative disorders, effects of neurodegeneration on human motor behavior, and heritable neurodegenerative disorders
  • Psychiatric disease: Schizophrenia, developmental risk factors for psychosis, the future of psychopharmacology, and perinatal and childhood risk factors in psychiatric diseases.
  • Neuron Biology: Neurogenesis, stem cells, reprogramming to treat psychiatric and neurological diseases, brain-gut interactions – a new hot topic, and critical phase of neuronal plasticity.


Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRneuro to follow the conversation

 


Speakers:
  • Co-Director and Research Professor, MBNI, Distinguished University Professor and Quarton Professor of Neurosciences, Department of Psychiatry, University of Michigan, Molecular and Behavorial
  • Swedish Pharmacologist, Nobel Prize Winner
  • Professor & Chair, Anatomy & Neuroscience, University College Cork in Ireland
  • Professor, Department of Psychology, University of British Columbia
  • Professor Laboratory of Genetics, Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease, The Salk Institute for Biological Studies
  • Professor, Department of Psychiatry, University of San Diego, School of Medicine
  • Professor, Department of Psychiatry and Neuroscience, Friedman Brain Institute, Chief, Brain Imaging Center, Chief, NARC Research Program, Icahn School of Medicine at Mount Sinai
  • Professor of Chemistry at the University of Manitoba
  • Professor of Molecular and Cellular Biology, Professor of Neurology, Center for Brain Science, Harvard University
  • Director, Division of Experimental Therapeutics, Director, Columbia Conte Center for Schizophrenia Research, Professor of Psychiatry and Neuroscience, Columbia University College of Physician
  • Executive Director of Orygen, Professor of Youth Mental Health at The University of Melbourne, and a Director of the Board of the National Youth Mental Health Foundation
  • Senior Research Fellow and Head of Psychiatry Discovery Research in CNS for the Neuroscience & Pain Research Unit at Pfizer, Inc.
  • Associate Professor, Program Director of Gene Discovery and Stem Cell Modeling Parkinson's Institute and Clinical Center
  • Adjunct Professor of Psychiatry, University of California, San Diego, Honorary Visiting Senior Fellow, University of Cambridge, UK, Chairman, Neuroscience Education Institute (NEI), Editor-in
  • Chair, Department of Physiology, Nathan Smith Davis Professor of Physiology, Professor in Physiology, Northwestern University, Feinberg School of Medicine
  • Neuropsychiatrist and Principal Investigator, Department of Psychiatry, Behavioural and Clinical Neuroscience Institute, University of Cambridge
  • Product Manager for Microscopy Systems, Andor Technology

Show Resources
Agenda
All times are Pacific Time
  • MAR 16, 2016 06:00 AM PDT
    Speaker: Huda Akil, PhD
  • MAR 16, 2016 07:30 AM PDT
    Speaker: Geraint Wilde, PhD
  • MAR 16, 2016 09:00 AM PDT
    Speaker: Stan Floresco, PhD
  • MAR 16, 2016 10:30 AM PDT
    Speaker: Stephen Stahl, PhD
  • MAR 16, 2016 10:30 AM PDT
    Speaker: Fred Gage, PhD
  • MAR 16, 2016 12:00 PM PDT
    Speaker: Kathleen Gough
  • MAR 16, 2016 12:00 PM PDT
    Speaker: D James Surmeier, PhD
  • MAR 16, 2016 01:30 PM PDT
    Speaker: Valerie Voon, MD, PhD
  • MAR 17, 2016 06:00 AM PDT
    Speaker: Arvid Carlsson, MD, PhD
  • MAR 17, 2016 07:30 AM PDT
    Speaker: John Cryan, PhD
  • MAR 17, 2016 07:30 AM PDT
    Speaker: Daniel Javitt, MD, PhD
  • MAR 17, 2016 09:00 AM PDT
    Speaker: Patrick McGorry, MD, PhD, FRCP, FRANZCP
  • MAR 17, 2016 09:00 AM PDT
    Speaker: Rita Goldstein, PhD
  • MAR 17, 2016 10:30 AM PDT
    Speaker: Birgitt Schuele, MD
  • MAR 17, 2016 10:30 AM PDT
    Speaker: Jay Giedd, PhD
  • MAR 17, 2016 12:00 PM PDT
    Speaker: Patricio O'Donnell, PhD
  • MAR 17, 2016 01:30 PM PDT
    Speaker: Takao Hensch, PhD
  • Psychiatric disease
  • MAR 16, 2016 06:00 AM PDT
    Speaker: Huda Akil, PhD
  • MAR 16, 2016 10:30 AM PDT
    Speaker: Stephen Stahl, PhD
  • MAR 16, 2016 01:30 PM PDT
    Speaker: Valerie Voon, MD, PhD
  • MAR 17, 2016 07:30 AM PDT
    Speaker: Daniel Javitt, MD, PhD
  • MAR 17, 2016 09:00 AM PDT
    Speaker: Rita Goldstein, PhD
  • MAR 17, 2016 10:30 AM PDT
    Speaker: Jay Giedd, PhD
  • Neural Circuitry
  • MAR 16, 2016 07:30 AM PDT
    Speaker: Geraint Wilde, PhD
  • MAR 16, 2016 09:00 AM PDT
    Speaker: Stan Floresco, PhD
  • MAR 16, 2016 12:00 PM PDT
    Speaker: Kathleen Gough
  • MAR 17, 2016 12:00 PM PDT
    Speaker: Patricio O'Donnell, PhD
  • Neuron Biology
  • MAR 16, 2016 10:30 AM PDT
    Speaker: Fred Gage, PhD
  • MAR 17, 2016 07:30 AM PDT
    Speaker: John Cryan, PhD
  • MAR 17, 2016 01:30 PM PDT
    Speaker: Takao Hensch, PhD
  • Neurodegenerative Disorders
  • MAR 16, 2016 12:00 PM PDT
    Speaker: D James Surmeier, PhD
  • MAR 17, 2016 10:30 AM PDT
    Speaker: Birgitt Schuele, MD
  • Inaugural Speaker
  • MAR 17, 2016 06:00 AM PDT
    Speaker: Arvid Carlsson, MD, PhD
  • Neurogenerative Disorders
  • MAR 17, 2016 09:00 AM PDT
    Speaker: Patrick McGorry, MD, PhD, FRCP, FRANZCP
Speakers

  • Huda Akil, PhD
    Co-Director and Research Professor, MBNI, Distinguished University Professor and Quarton Professor of Neurosciences, Department of Psychiatry, University of Michigan, Molecular and Behavorial
    Biography
      Huda Akil is a neuroscientist whose pioneering research has contributed to the understanding of the neurobiology of emotions. She was born in Damascus, Syria and was educated in Lebanon and the United States of America. She is the co-director of the Molecular and Behavioral Neuroscience Institute with Stanley Watson, and Gardner C. Quarton Distinguished Professor of Neurosciences in the Department of Psychiatry at the University of Michigan Medical School.[1] She is also the co-director of the University of Michigan node of the Pritzker Neuropsychiatric Disorders Research Consortium.[2] Her undergraduate education was at the American University of Beirut. She completed doctoral work at the University of California Los Angeles and did postdoctoral work at Stanford University. She is a former president of the Society for Neuroscience (2002-2003) and an elected member of the National Academy of Sciences (2011).
    • Arvid Carlsson, MD, PhD
      Swedish Pharmacologist, Nobel Prize Winner
      Biography
        Arvid Carlsson, Swedish pharmacologist who, along with Paul Greengard and Eric Kandel, was awarded the 2000 Nobel Prize for Physiology or Medicine for his research establishing dopamine as an important neurotransmitter in the brain. Carlsson received a medical degree from the University of Lund in 1951 and subsequently held teaching positions there until 1959, when he became professor of pharmacology at the University of Gothenburg. When Carlsson began his pioneering studies in the 1950s, scientists thought that dopamine worked only indirectly, by causing brain cells to make another neurotransmitter, noradrenaline. Using a sensitive test that he had devised, Carlsson detected particularly high levels of the compound in areas of the brain that controlled walking and other voluntary movements. In animal experiments he showed that depletion of dopamine impairs the ability to move. When Carlsson treated dopamine-depleted animals with the amino acid l-dopa, the symptoms disappeared, and the animals moved normally again. This led to the use of l-dopa as a treatment for Parkinson disease, and it eventually became the single most important medication for the disease. Carlsson's work also contributed to an understanding of the relationship between neurotransmitters and mental states and led to the introduction of new antidepressant drugs.
      • John Cryan, PhD
        Professor & Chair, Anatomy & Neuroscience, University College Cork in Ireland
        Biography
          John F. Cryan is Professor & Chair, Dept. of Anatomy & Neuroscience, University College Cork. He received a B.Sc. (Hons) and PhD from the National University of Ireland, Galway, Ireland. He was a visiting fellow at the Dept Psychiatry, University of Melbourne, Australia (1997-1998), which was followed by postdoctoral fellowships at the University of Pennsylvania, Philadelphia, USA and The Scripps Research Institute, La Jolla, California. He spent four years at the Novartis Institutes for BioMedical Research in Basel Switzerland, as a LabHead, Behavioural Pharmacology prior to joining UCC in 2005 where he was a Senior Lecturer in Pharmacology in the School of Pharmacy and in the Dept. Pharmacology & Therapeutics UCC. Currently he is also a Principal Investigator in the Alimentary Pharmabiotic Centre Prof. Cryan has an H-Index of 57 (Google Scholar) having published over 250 peer-reviewed articles and book chapters including articles in high-impact journals such as PNAS, Neuron, Nature Reviews Neurosci. Molecular Psychiatry, Biological Psychiatry, Progress in Neurobiology, Nature Reviews Drug Discovery, Gastroenterology, Gut and Journal of Neuroscience. He has edited books on "Behavioural Neurogenetics" (Springer Press, 2012) on "Depression: From Psychopathology to Pharmacotherapy" (Karger Press, 2010) and "Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease" (Springer Press, 2014). Prof. Cryan was recently selected as a Highly Cited Researcher by Thomson Reuters. Those researchers who, within an ESI-defined field, published Highly Cited Papers were judged to be influential, so the production of multiple top 1% papers was interpreted as a mark of exceptional impact. Professor Cryan, as a member of the Highly Cited Researcher List is also included in the 2014 The World's most Influential Scientific Minds
        • Stan Floresco, PhD
          Professor, Department of Psychology, University of British Columbia
          Biography
            Dr. Stan Floresco is a Professor of Psychology and member of the Brain Research Centre at the University of British Columbia, and a Fellow of the American College of Neuropsychopharmacology. He received his all of his postgraduate degrees from the UBC, obtaining his Ph.D in 2000. He subsequently conducted postdoctoral research in the Department of Neuroscience at the University of Pittsburgh, after which he returned to UBC to take up a faculty position in 2003.. Dr. Floresco has published over 90 peer-reviewed articles on his research employing behavioral and neurophysiological approaches to study neural circuits within the dopamine system that facilitate higher-order cognitive functions such as cognitive flexibility and cost/benefit decision making, and how dysfunction in these circuits may relate to psychiatric disease. He currently serves as an associate editor for the journals Cognitive, Affective and Behavioral Neuroscience and Neuropsychopharmacology, and in 2010, he was awarded the American Psychological Association's Early Career Award.
          • Fred Gage, PhD
            Professor Laboratory of Genetics, Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease, The Salk Institute for Biological Studies
            Biography
              Fred "Rusty" Gage Professor in the Laboratory of Genetics at the Salk Institute, and has concentrated on the adult central nervous system and the unexpected plasticity and adaptability that remains throughout the life of all mammals. His work may lead to methods of replacing brain tissue lost to stroke or Alzheimer's disease and repairing spinal cords damaged by trauma. He was the President-elect of the ISSCR in 2012. In 1998, Fred H. Gage and Peter Eriksson discovered and announced that the human brain produces new nerve cells in adulthood. Until then, it had been assumed that humans are born with all the brain cells they will ever have. Gage's lab showed that, contrary to years of dogma, human beings are capable of growing new nerve cells throughout life. Small populations of immature nerve cells are found in the adult mammalian brain, and Gage is working to understand how these cells can be induced to become mature nerve cells. His team is investigating how such cells can be transplanted back to the brain and spinal cord. They have showed that physical exercise can enhance the growth of new brain cells in the hippocampus, a brain structure that is important for the formation of new memories. Furthermore, his team is examining the underlying molecular mechanisms that are critical to the birth of new brain cells, work that may lead to new therapeutics for neurodegenerative conditions. Finally, his lab studies the genomic mosaicism that exists in the brain as a result of "jumping genes," mobile elements, and DNA damage that occurs during development. Specifically, he is interested in how this mosaicism may lead to difference in brain function between individuals.
            • Jay Giedd, PhD
              Professor, Department of Psychiatry, University of San Diego, School of Medicine
              Biography
                Dr. Giedd completed his undergraduate medical education at the University of North Dakota Medical School in 1986, and entered the Residency Program at the Menninger School of Psychiatry in 1986. He transferred to the Barrow Neurological Institute in 1988, and completed his residency in Psychiatry in 1989. He was a postgraduate fellow in the Child and Adolescent Psychiatry Program at Duke University School of Medicine from 1989 to 1991, and then accepted a position as Clinical Staff Fellow at the Child Psychiatry Branch of the National Institute of Mental Health (NIMH). He was promoted to Senior Staff Clinician at the NIMH in 1997, and he was named the Chief of the Brain Imaging Section in 2001; in 2010 he was appointed Adjunct Professor at the Johns Hopkins Bloomberg School of Public Health. Dr. Giedd is board certified in General Psychiatry by the American Board of Psychiatry and Neurology (1992), with added qualifications in Geriatric Psychiatry (1994), and by the American Academy of Child and Adolescent Psychiatry
              • Rita Goldstein, PhD
                Professor, Department of Psychiatry and Neuroscience, Friedman Brain Institute, Chief, Brain Imaging Center, Chief, NARC Research Program, Icahn School of Medicine at Mount Sinai
                Biography
                  Dr. Goldstein is a Professor of Psychiatry with a secondary appointment in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai (ISMMS) in NY. Dr. Goldstein is chief of the Brain Imaging Center (BIC) at ISMMS; she also directs the NARC (Neuropsychoimaging of Addiction and Related Conditions) research group that uses multimodality functional neuroimaging methods to explore the neurobiological basis of impaired cognitive and emotional functioning in human drug addiction and other disorders of self-control. An important application of this research is to facilitate the development of intervention modalities that would improve treatment outcome in drug addiction and other chronically relapsing disorders of self-regulation. Nationally and internationally known for her neuroimaging and neuropsychological studies in drug addiction, Dr. Goldstein formulated a theoretical model known as Impaired Response Inhibition and Salience Attribution (iRISA). The model uses multiple neuroimaging modalities-including MRI, EEG/ERP, PET and neuropsychological tests-to explore the neurobiological underpinnings of iRISA in drug addiction and related conditions. Dr. Goldstein became fellow of the ACNP in January 2015, receiving the prestigious Joel Elkes Research Award in 2012 and the Jacob P. Waletzky Award in 2013. As BIC chief Dr. Goldstein is striving to facilitate optimized research use of ISMMS's state-of-the-art brain imaging facilities at the Translational and Molecular Imaging Institute (TMII). Adopting a translational (3T, 7T, PET/MR; human and non-human imaging), developmental and cross-generational approach, BIC has been developing a standardized processing pipelines to acquire, analyze and manage a comprehensive set of brain scans across a myriad of neuropsychiatric disorders with the goal of accelerating the development of large-scale gene-brain-behavior datasets essential for revolutionizing our understanding of the brain.
                • Kathleen Gough
                  Professor of Chemistry at the University of Manitoba
                  Biography
                    Professor Kathleen Gough obtained her PhD in 1984 (University of Manitoba) on overtone vibrational spectra of aromatic molecules. She was a Research Associate at the National Research Council in Ottawa in the Henry Mantsch group, under Dr. William Murphy, and an NSERC postdoctoral fellow in theoretical chemistry with Prof. Richard Bader (McMaster University), where she focussed on the experimental and theoretical analysis of Raman scattering intensities in hydrocarbons. She is presently a Professor of Chemistry at the University of Manitoba. Her expertise is the development of protocols for preparation and FTIR and Raman spectrochemical imaging of fresh, snap-frozen, unfixed tissue.
                  • Takao Hensch, PhD
                    Professor of Molecular and Cellular Biology, Professor of Neurology, Center for Brain Science, Harvard University
                    Biography
                      Dr. Hensch holds joint faculty appointments in Neurology at Harvard Medical School at Boston Children's Hospital and in Molecular and Cellular Biology at Harvard University's Center for Brain Science. He received his Ph.D. from the University of California, San Francisco, and helped to launch the RIKEN Brain Science Institute in Japan, where he continues to serve as special advisor. Dr. Hensch has received the Society for Neuroscience Young Investigator Award in both the US (2005) and in Japan (2001 Tsukahara Prize). He also received a National Institutes of Health Director's Pioneer Award in 2007. He serves on the editorial board of several peer-reviewed journals, including Journal of Neuroscience, Journal of Neurodevelopmental Disorders, Neural Development, Neuroscience Research, Frontiers in Neural Circuits, and Neuron. Dr. Hench's research involves the study of critical periods of brain development. By applying cellular and molecular biology techniques to neural systems, his lab has identified pivotal inhibitory circuits that orchestrate structural and functional rewiring of connections in response to early sensory experience. His work affects not only the basic understanding of brain development, but also therapeutic approaches to devastating cognitive disorders later in life.
                    • Daniel Javitt, MD, PhD
                      Director, Division of Experimental Therapeutics, Director, Columbia Conte Center for Schizophrenia Research, Professor of Psychiatry and Neuroscience, Columbia University College of Physician
                      Biography
                        Daniel C Javitt, MD, PhD, is Professor of Psychiatry and Neuroscience at Columbia University College of Physicians and Surgeons, where he directs the Division of Experimental Therapeutics as well as the Columbia Conte Center for Schizophrenia Research in New York City. Additionally, Dr Javitt serves as Director of Schizophrenia Research at Nathan Kline Institute for Psychiatric Research, a New York State Office of Mental Health-supported research facility. He received his MD and PhD degrees from Albert Einstein College of Medicine. His research focuses on mechanisms underlying negative symptoms and cognitive deficits in schizophrenia and other serious mental disorders, with particular emphasis on NMDA receptors and neurophysiological assessment, and on new treatment development using both pharmacological and brain stimulation approaches. Dr Javitt has published over 250 articles on issues related to normal brain function, NMDA receptors and schizophrenia. He has received awards for his research from numerous organizations, including the Penwalt Resident Research Award from the American Psychiatric Association; The Kempf Fund Award for Research Development in Psychobiological Psychiatry from the American Psychiatric Association; the A.E. Bennett Basic Science Award from the Society for Biological Psychiatry; the Joel Elkes Research Award from the American College of Neuropsychopharmacology; and a MERIT award from the National Institutes of Mental Health. Dr Javitt serves on the editorial board of several prestigious journals including Schizophrenia Bulletin, Schizophrenia Research, and American Journal of Psychiatry. He is a Fellow of the American College of Neuropsychopharmacology and an advisory board member for the Brain and Behavior Research Foundation.
                      • Patrick McGorry, MD, PhD, FRCP, FRANZCP
                        Executive Director of Orygen, Professor of Youth Mental Health at The University of Melbourne, and a Director of the Board of the National Youth Mental Health Foundation
                        Biography
                          Professor Patrick McGorry is the Executive Director of Orygen, Professor of Youth Mental Health at The University of Melbourne, and a Director of the Board of the National Youth Mental Health Foundation (headspace). He is a world-leading researcher in the area of early psychosis and youth mental health, and has a strong interest in promoting the mental health of the homeless, refugees and asylum seekers. His work has played a critical role in the development of safe, effective treatments and innovative research into the needs of young people with emerging mental disorders, notably psychotic and severe mood disorders. He has also played a major part in the transformational reform of mental health services to better serve the needs of vulnerable young people. Professor McGorry was a key architect of the headspace model and has been successful in advocating with colleagues for its national expansion. He has successfully advocated for the establishment of a national early psychosis programme based on the Early Psychosis Prevention and Intervention Centre model. He is frequently asked to advise on youth mental health policy both nationally and internationally. Professor McGorry has published extensively in the specialist literature, and serves as Editor-in-Chief of Early Intervention in Psychiatry. He is a Fellow of the Academy of the Social Sciences in Australia, and the current President of the Society for Mental Health Research, and the President-Elect of the Schizophrenia International Research Society.
                        • Patricio O'Donnell, PhD
                          Senior Research Fellow and Head of Psychiatry Discovery Research in CNS for the Neuroscience & Pain Research Unit at Pfizer, Inc.
                          Biography
                            Patricio O'Donnell is a Senior Research Fellow and Head of Psychiatry Discovery Research in CNS for the Neuroscience & Pain Research Unit at Pfizer, Inc. in Cambridge, Ma. Dr. O'Donnell grew up in Buenos Aires, Argentina and earned his M.D. and Ph.D. degrees from the University of Buenos Aires. Dr. O'Donnell worked as a postdoctoral fellow with Anthony Grace at the University of Pittsburgh, where he pioneered studies on the physiological properties of the nucleus accumbens, and then moved on to establishing his own research program at Albany Medical College. In 2006 he was recruited by the University of Maryland, and in 2013 he moved to Pfizer. Dr. O'Donnell's research focuses on the modulation of cortical brain circuits by dopamine, how this modulation matures during adolescence, and the mechanisms by which it becomes dysfunctional in rodent models of psychiatric disorders with the goal of identifying novel therapeutic targets. He is the recipient of numerous awards including the 2010 National Alliance for Schizophrenia and Depression Distinguished Investigator Award. Dr. O'Donnell is a fellow in the American College of Neuropsychopharmacology (ACNP), chaired several conferences including the 2009 Gordon Conference on Catecholamines and is currently the chair of the Winter Conference on Brain Research. Dr. O'Donnell has authored over 80 scientific papers, served or serves on the Editorial Boards of the Journal of Neuroscience, Neuropsychopharmacology, The International Journal of Neuropsychopharmacology, Schizophrenia Bulletin, and the Journal of Pharmacology & Experimental Therapeutics, among others, and sat on advisory committees of the National Institutes of Health. He serves on the scientific advisory board of several private foundations and has advised major pharmaceutical and biotech companies. Before joining Pfizer, Dr. O'Donnell was a Professor of Anatomy & Neurobiology and Psychiatry at the University of Maryland School of Medicine.
                          • Birgitt Schuele, MD
                            Associate Professor, Program Director of Gene Discovery and Stem Cell Modeling Parkinson's Institute and Clinical Center
                            Biography
                              Birgitt Schüle, MD, studied medicine at the Georg-August University, Göttingen and Medical University Lübeck, Germany from 1993-2001. She received her doctoral degree (Dr. med.) for her medical thesis in neurophysiology from the Georg-August University, Göttingen in 2001. Dr. Schüle worked during her neurological internship (2001-2002) at the Medical University Lübeck with Dr. Christine Klein on genetic forms of PD and dystonia. From 2003-2005, Dr. Schüle completed a postdoctoral fellowship in the laboratory of Dr. Uta Francke, Department of Genetics, Stanford University School of Medicine, before joining the Parkinson's Institute in October 2005. Dr. Schüle leads the genetics and biomarker program, since 2008, she has built a stem cell program developing novel "disease in-a-dish" models of Parkinson's disease using patient-derived induced pluripotent stem cells. In 2014, she became the director of the brain bank at the Parkinson's Institute.
                            • Stephen Stahl, PhD
                              Adjunct Professor of Psychiatry, University of California, San Diego, Honorary Visiting Senior Fellow, University of Cambridge, UK, Chairman, Neuroscience Education Institute (NEI), Editor-in
                              Biography
                                Dr. Stephen M. Stahl received his undergraduate and medical degrees from Northwestern University in Chicago, as a member of the honors program in Medical Education and his Ph.D. degree in pharmacology and physiology from the University of Chicago. Dr. Stahl has trained in three specialties: internal medicine at the University of Chicago; neurology at the University of California in San Francisco; and psychiatry at Stanford University. He is board certified in psychiatry. Dr. Stahl has held faculty positions at Stanford University, the University of California at Los Angeles, the Institute of Psychiatry London, the Institute of Neurology London, and, currently, as Adjunct Professor of Psychiatry at the University of California at San Diego. Dr. Stahl was also Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK for several years. Dr. Stahl's major interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the internet and teaching how to teach. Dr. Stahl has conducted numerous research projects during his career awarded by the National Institute of Mental Health, by the Veterans Administration and by the pharmaceutical industry. Author of more than 350 articles and chapters, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has edited three books, and written four others, including the best-selling textbook, Essential Psychopharmacology, now in its third edition and the best selling clinical manual, Essential Psychopharmacology Prescriber's Guide.
                              • D James Surmeier, PhD
                                Chair, Department of Physiology, Nathan Smith Davis Professor of Physiology, Professor in Physiology, Northwestern University, Feinberg School of Medicine
                                Biography
                                  Dr. James Surmeier is the Nathan Smith Davis Professor and Chair of the Department of Physiology at the Feinberg School of Medicine at Northwestern University and Director of the Morris K. Udall Research Center of Research Excellence for Parkinson's Disease at Northwestern University. Dr. Surmeier received his PhD in Physiology and Biophysics from the University of Washington in 1983. He trained with leaders in the field of neurophysiology, including Dr. Arnold Towe, Dr. William Willis and Dr. Stephen Kitai. In 1998, he moved to the Department of Physiology at Northwestern University and assumed his current position in 2001. Dr. Surmeier's research program focuses on the ionic mechanisms underlying neural activity in the basal ganglia and their modulation by activation of G-protein coupled receptors, particularly those for dopamine. He has pioneered the application of modern patch clamp and single cell gene profiling approaches to understanding basal ganglia physiology, authoring over 100 peer-reviewed publications in journals such as Science, Nature, Neuron, Nature Neuroscience and the Journal of Neuroscience. Dr. Surmeier has served in several advisory capacities lo the National Institutes of Health, including chairing study sections for NINDS and acting as a Councilor for NIAAA. He also serves on the scientific advisory boards of the Hereditary Disease Foundation, Dystonia Foundation and the Tourette Syndrome Association and a number of editorial boards. He has received many scientific awards including the NARSAD Established Investigator award, the Riker Award, the Picower Foundation Award and the Jacob Javits Neurosciencc Investigator Award.
                                • Valerie Voon, MD, PhD
                                  Neuropsychiatrist and Principal Investigator, Department of Psychiatry, Behavioural and Clinical Neuroscience Institute, University of Cambridge
                                  Biography
                                    Valerie Voon is a neuropsychiatrist and neuroscientist at the University of Cambridge. She is a Medical Research Council Senior Clinical Fellow. She completed her psychiatry residency at the University of Toronto, a research fellowship at the National Institute of Neurological Disorders and Stroke and a PhD in neuroscience through the University College London. Her research group uses multimodal approaches to understand mechanisms underlying impulsivity and compulsivity across repetitive behaviours. Dr. Voon's research group focuses on mechanisms underlying impulsivity and compulsivity and relevance to disorders of addiction across both drug and natural rewards. She uses a multimodal approach including anatomical and functional MRI, PET, pharmacological challenges, computational modelling and cognitive neuroscience. She has published extensively with over 100 peer-reviewed publications including in high impact journals such as Neuron, Molecular Psychiatry, Lancet Neurology, Annals of Neurology, Brain and Biological Psychiatry. She is a Fellow of the American Neuropsychiatric Association.
                                  • Geraint Wilde, PhD
                                    Product Manager for Microscopy Systems, Andor Technology
                                    Biography
                                      Dr Geraint Wilde studied Pharmacology at the University of Leeds, before proceeding to postgraduate studies at the University of Southampton. After attaining a PhD in 1997 Geraint continued his interest in neuroscience with a post-doctoral position at the University of Warwick. Following this post, he then moved to the University of Liverpool to work in the laboratory of Professor Michael White, focusing on intracellular signalling and gene expression through live cell imaging. Geraint used microscopy through most of his research career, and having caught the imaging bug, decided to pursue a commercial career in this field. Having worked for a few companies selling microscopy products, Geraint joined Andor Technology in 2009. Since then he has moved into the role of Product Manager for Microscopy Systems, focusing on product development, applications, delivery to market and support.
                                    Sponsored By

                                    For information on becoming a sponsor or exhibitor, please click here.


                                    Continuing Education (CME/CE/CEU) Credits

                                    The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                    Committee

                                    To download the Program Committee brochure here.


                                    • Anthony Grace, PhD

                                      Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                      See more See less
                                    • Ottavio Arancio MD, Ph.D

                                      Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                      See more See less
                                    • Szczepan Baran, VMD, MS

                                      Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                      See more See less
                                    • Floyd Bloom, M.D.

                                      Floyd E. Bloom, M.D.is professor emeritus at The Scripps Research Institute in La Jolla, California. He was chairman emeritus of the department of neuropharmacology at The Scripps Research Institute, past president of the American Association for the Advancement of Science ...

                                      See more See less
                                    • Pierre-Antoine Gourraud, PhD, MPH

                                      Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                      See more See less
                                    • Ulrich Hengst, PhD

                                      Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                      See more See less
                                    • Suzanne Haber, PhD

                                      Dr. Haber's research focuses on the neural network underlying learning and decision-making that leads to action plan development. The cortico-basal ganglia-thalamic system is central to this network and comprises a diverse group of structures involved in reward and motivation ...

                                      See more See less
                                    • Paul Mathews, PhD

                                      Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                      See more See less
                                    • Philip Mitchell, AM, MB BS (Hons I), MD, FRANZCP, FRCPsych

                                      Philip Mitchell is Scientia Professor and Head of the School of Psychiatry at University of New South Wales in Sydney, Australia; Member, Australian National Health and Medical Research Council Research Committee; Vice-President (Governance), International Society for Bipolar ...

                                      See more See less
                                    • Robin Murray, FRS

                                      Robin Murray is Professor of Psychiatric Research at the Institute of Psychiatry, and indeed has spent most of his working life there apart from one year in the USA: fortunately the latter did not do him too much harm. His particular interest is in understanding the causes of ...

                                      See more See less
                                    • Kim Quang Do, PhD

                                      Following a career in basic research in chemistry, molecular biology and neurobiology (glutatmate and nitric oxide transmission, neuro Research Institute (Zurich University), I moved towards "bench to bed" research at the Center for Psychiatric Neuroscience (Department of ...

                                      See more See less
                                    • Stephanie Willerth, PhD

                                      Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                      See more See less
                                    Help

                                    General LabRoots Questions

                                    For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                    Contact us

                                    Virtual Events and Webinars

                                    Supported Configurations

                                    • Operating System Internet Explorer Firefox Chrome Safari
                                      Vista IE8+ FF10+ Chrome15+
                                      Windows 7 IE8+ FF10+ Chrome15+
                                      Windows 8 IE10 FF10+ Chrome15+
                                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                                    • Cookie settings: session cookies enabled
                                    • Browser configuration must have JavaScript enabled
                                    • Adobe Flash player 10.2 or later

                                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                    Internet Connection

                                    • A minimum of 100Kbps is recommended for audio-only events
                                    • A minimum of 300Kbps is recommended for speaker on-video events

                                    Computer Equipment

                                    • Screen Resolution: Minimum 1024x768
                                    • Video Card: 65,000 colors minimum
                                    • Sound card and speakers (or headphones) for hearing webcast in full format
                                    • Audio Card: 16-bit minimum
                                    • RAM: 512MB of free RAM

                                    Firewall Protocol

                                    • HTTP on port 80 or HTTPS on port 443
                                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                    Work-At-Home Attendees

                                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                    For A Seamless Experience

                                    When using a mobile device, FREE Mobile Apps are available:

                                    - For viewing Webinars:

                                    - For viewing Virtual Events

                                    Attendee Guide

                                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                    Virtual Event and Webinar Support:

                                    Continuing Education (CME/CE) Support

                                    Loading Comments...
                                    Show Resources